Comparison of effectiveness and safety outcomes of abiraterone versus enzalutamide in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis

• Main Authors: Xin Wang (Author), yang hui (Author), Shihui Wang (Author), Xiaopeng Hu (Author), Xiaojia Yu (Author), Wei Wang (Author), Xiaodong Zhang (Author), Lihong Liu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2020-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Purpose: To compare the effectiveness and safety between abiraterone and enzalutamide in the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC). Methods: We systematically searched for relevant articles from PubMed, Cochrane, Embase from their inception through Novemb...